Nautilus Biotechnology, Inc.
NAUT
$2.51
$0.041.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -18.28% | -13.87% | -19.75% | -15.78% | -5.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.80% | -18.99% | -17.76% | -12.79% | -0.10% |
| Operating Income | 22.80% | 18.99% | 17.76% | 12.79% | 0.10% |
| Income Before Tax | 21.67% | 17.46% | 16.53% | 11.30% | -3.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 21.67% | 17.46% | 16.53% | 11.30% | -3.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.67% | 17.46% | 16.53% | 11.30% | -3.35% |
| EBIT | 22.80% | 18.99% | 17.76% | 12.79% | 0.10% |
| EBITDA | 22.84% | 19.04% | 17.94% | 12.86% | -0.09% |
| EPS Basic | 21.37% | 18.00% | 17.12% | 12.02% | -2.72% |
| Normalized Basic EPS | 23.31% | 17.95% | 17.15% | 11.98% | 8.03% |
| EPS Diluted | 21.37% | 18.00% | 17.12% | 12.02% | -2.72% |
| Normalized Diluted EPS | 23.31% | 17.95% | 17.15% | 11.98% | 8.03% |
| Average Basic Shares Outstanding | -0.41% | 0.68% | 0.71% | 0.81% | 0.65% |
| Average Diluted Shares Outstanding | -0.41% | 0.68% | 0.71% | 0.81% | 0.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |